Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yingyi Ye, Shuhong Huang & Yingying Wu. (2019) UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway. Cancer Management and Research 11, pages 2339-2348.
Read now
Read now
Hong-Hai Li, Xian-Xu Song, Bo Liu & Wen-Ping Yang. (2019) UNBS5162 as a novel naphthalimide holds efficacy in human gastric carcinoma cell behaviors mediated by AKT/ERK signaling pathway. Drug Development and Industrial Pharmacy 45:8, pages 1306-1312.
Read now
Read now
Articles from other publishers (4)
Yang Liu, Guodong Liang, Tingting Zhou & Zengshan Liu. (2019) Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway. Pathology & Oncology Research 26:2, pages 1079-1088.
Crossref
Crossref
Qiang Wang & Wei Shi. (2019) UNBS5162 inhibits SKOV3 ovarian cancer cell proliferation by regulating the PI3K/AKT signalling pathway. Oncology Letters.
Crossref
Crossref
Yan‑Xia Huang, Xin‑Gang Nie, Guang‑Da Li, Dong‑Sheng Fan, Li‑Li Song & Xin‑Lin Zhang. (2018) Downregulation of microRNA‑182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation. International Journal of Oncology.
Crossref
Crossref
Xueli Shi, Liu Yang, Jun Xie, Yumei Zhao, Junzi Cong, Zhiping Li, Haiyan Li, Xianzhi Cheng & Jinghui Fan. (2018) UNBS5162 inhibits proliferation of human melanoma cells by inducing apoptosis via the PI3K/Akt pathway. Molecular Medicine Reports.
Crossref
Crossref